Awardee OrganizationUNIVERSITY OF CALIFORNIA LOS ANGELES
Description
Abstract Text
PROJECT SUMMARY
Abdominal cancers are a devastating cause of morbidity and mortality worldwide. For example, hepatocellular
carcinoma (HCC) has a grim five-year survival rate of less than 20% and is the fastest rising cause of cancer-
related deaths in the U.S. Early and accurate diagnosis is crucial, as curative treatment is feasible by surgical
resection and/or focal ablation. Compared to surgery, focal ablation reduces hospital stay, increases
preservation of surrounding normal tissues, and decreases treatment-related morbidities. However, focal
ablation still faces critical limitations in applicability and effectiveness due to inadequate image guidance and
procedural accuracy provided by current approaches. Consequently, there is a pressing need to establish new
minimally invasive interventions to improve the diagnosis and treatment of abdominal cancers.
Conventional abdominal interventions rely on image guidance by ultrasound and/or computed tomography (CT),
which can fail to provide sufficient visualization of the cancerous lesions. In addition, CT utilizes ionizing radiation
and cannot be used for real-time imaging throughout an intervention. Magnetic resonance imaging (MRI) has
crucial advantages that make it ideal for real-time guidance of abdominal interventions: it is the best and/or only way
to visualize HCC and several types of abdominal cancers, has no ionizing radiation, and has the potential for real-
time imaging of abdominal organs that are constantly in motion. However, current real-time MRI suffers from
compromises in image quality, time latency, and difficulties in tracking the devices and tissue targets during
motion. Furthermore, the narrow physical space of MRI scanners severely impedes the physician’s access to the
patient inside the scanner during imaging. As a result, current MRI-guided interventions require cumbersome
workflows that hamper the accuracy and efficiency.
The objective of this proposal is to overcome these challenges and enable real-time MRI-guided abdominal
interventions. The interdisciplinary research team will leverage synergistic innovations in (1) real-time MRI and
computer-aided guidance methods, (2) MRI-compatible robotics, and (3) computer-aided feedback control
methods and interactive user interfaces to create a new real-time MRI-guided robotic system. The system will
be evaluated in programmable dynamic tissue phantoms and in vivo pig liver models to achieve safe, accurate,
and efficient needle placement in moving targets – the foundation for all abdominal interventions. This new
robotic system will enable next-generation real-time MRI-guided interventions that can positively impact the
diagnosis and treatment of patients with liver tumors and abdominal cancers.
Public Health Relevance Statement
PROJECT NARRATIVE
Image-guided minimally invasive interventions, including targeted biopsy and focal ablation, promise to be safe and
effective strategies for the diagnosis and treatment of abdominal cancers, but currently face critical limitations due
to inadequate image guidance and procedural accuracy provided by existing technologies. This work will overcome
these challenges by creating a new real-time magnetic resonance imaging (MRI) guided robotic system based on
synergistic innovations in real-time MRI and computer-aided guidance methods, MRI-compatible robotics, feedback
control methods, and interactive user interfaces. The new system will be evaluated in programmable dynamic
tissue phantoms and in vivo pig liver models to demonstrate its safety, accuracy, and efficiency for needle
placement in moving targets, which will establish the foundation for a new generation of minimally invasive
interventions to improve the management of abdominal cancers.
National Institute of Biomedical Imaging and Bioengineering
CFDA Code
286
DUNS Number
092530369
UEI
RN64EPNH8JC6
Project Start Date
06-September-2022
Project End Date
30-June-2026
Budget Start Date
01-July-2024
Budget End Date
30-June-2025
Project Funding Information for 2024
Total Funding
$632,038
Direct Costs
$405,152
Indirect Costs
$226,886
Year
Funding IC
FY Total Cost by IC
2024
National Institute of Biomedical Imaging and Bioengineering
$632,038
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5R01EB031934-03
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R01EB031934-03
Patents
No Patents information available for 5R01EB031934-03
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R01EB031934-03
Clinical Studies
No Clinical Studies information available for 5R01EB031934-03
News and More
Related News Releases
No news release information available for 5R01EB031934-03
History
No Historical information available for 5R01EB031934-03
Similar Projects
No Similar Projects information available for 5R01EB031934-03